© 2022 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
December 13, 2009
Many patients who chose mastectomy were not at increased breast-cancer risk and may have done so based on a failed attempt at breast-conservation surgery.
December 12, 2009
Doubling the dose of fulvestrant increases the time to disease progression in the treatment of postmenopausal women with breast cancer.
About 10 months of neoadjuvant letrozole is optimal for breast-conserving surgery in patients with early breast cancer.
Lung cancer deaths are significantly less common in breast cancer patients who are treated with anti-estrogens.